Deciphering the gene regulatory circuitry governing chemoresistance in Triple-Negative Breast Cancer
Lusby, R.; Mariappan, A.; Zhang, Z.; Tiwari, V. K.
Show abstract
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype, due in part to extensive intratumoral heterogeneity, high rates of metastasis and chemoresistance, leading to poor clinical outcomes. Despite progress, the mechanistic basis of chemotherapy resistance in TNBC patients remains poorly understood. Here, using single-cell transcriptome datasets of matched longitudinal TNBC chemoresponsive and chemoresistant patient cohorts, we discover cell subpopulations associated with chemoresistance and the signature genes defining these populations. Notably, we show that the expression of these chemoresistance genes is driven via a set of TNBC super-enhancers and transcription factor networks across TNBC subtypes. Furthermore, genetic screens reveal that a subset of these transcription factors is essential for the survival of TNBC cells and their loss increases sensitivity to chemotherapeutic agents. Overall, our study has revealed transcriptional regulatory networks underlying chemoresistance and suggests novel avenues to stratify and improve the treatment of patients with a high risk of developing resistance.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Multiplexed RNA-FISH-guided Laser Capture Microdissection RNA Sequencing Improves Breast Cancer Molecular Subtyping, Prognostic Classification, and Predicts Response to Antibody Drug Conjugates 97%
- Oncogenic RAS activity predicts response to chemotherapy and outcome in lung adenocarcinoma 96%
- Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer PDXs 96%
Similar papers in this journal
Similar papers in this journal
- Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome 96%
- Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages 95%
- Cell cycle alterations associate with a redistribution of mutation rates across chromosomal domains in human cancers 95%
Similar papers in this journal
- Aberrant transcript usage induces homologous recombination deficiency and predicts therapeutic responses 97%
- CIP2A interacts with TopBP1 and is selectively essential for DNA damage-induced basal-like breast cancer tumorigenesis 96%
- Single cell transcriptomic heterogeneity in invasive ductal and lobular breast cancer cells 96%
Similar papers in this journal
- Determination of permissive and restraining cancer-associated fibroblast (DeCAF) subtypes 96%
- Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic drivers 96%
- Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.